Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
Submitted by
admin
on November 8, 2024 - 12:03am
Source:
Medical Devices and Diagnostics Industry
News Tags:
Medtech
JNJ
Varipulse
FDA
atrial fibrillation
Medtronic
Boston Scientific
Headline:
J&J Joins Medtronic & Boston Sci in PFA Race with FDA Approval of Varipulse
snippet:
J&J's Varipulse platform receives FDA approval for treating drug-refractory paroxysmal atrial fibrillation.
The approval is backed by the admIRE study.
Varipulse competes alongside Medtronic’s and Boston Scientific’s offerings.
Do Not Allow Advertisers to Use My Personal information
